CDC study strongly underscores progress made by industry voluntary labeling guidelines
Monday, 06 January 2014 00:06
Jan. 6, 2014 22:33 UTC

CDC study strongly underscores progress made by industry voluntary labeling guidelines

CDC study finds high adherence to CHPA voluntary guidelines, FDA recommendations for OTC pediatric liquid medications

WASHINGTON--(BUSINESS WIRE)-- The Consumer Healthcare Products Association (CHPA) says the makers of over-the-counter (OTC) pediatric liquid medications have made significant progress in carrying out voluntary efforts to promote safe use through standardized dosing directions and dosing devices, as underscored by the results of a Centers for Disease Control and Prevention (CDC) study released today in “Pediatrics.”

In 2009, CHPA members approved voluntary labeling guidelines for all pediatric liquid medications in an effort to reduce the potential for dosing errors. Following reports of unintentional overdoses in 2011, the U.S. Food and Drug Administration (FDA) finalized similar recommendations for standardizing labeling and dosing devices included with OTC liquid medications.

Today’s “Pediatrics” article, “Adherence to Label and Device Recommendations for Over-the-Counter Pediatric Liquid Medications,” discusses the results of a study conducted by the Centers for Disease Control and Prevention (CDC) to assess recommendation adherence for national brand name orally ingested OTC liquid pediatric analgesics/antipyretics and

cough, cold, and allergy medications available after the FDA guidance was finalized. The report found high levels of adherence to most recommendations provided in the final FDA Guidance as well as the CHPA guideline.

“This report shows that our industry is making great progress, and it demonstrates our commitment to proactively working to empower consumers to safely use our products in order to reduce treatment errors in children,” said Barbara Kochanowski, CHPA’s vice president, Regulatory & Scientific Affairs. “Hand in hand with our efforts to improve labeling is our commitment to educating parents about the importance of safe medicine storage. Accidental, unsupervised medicine ingestions are the leading cause of emergency department visits related to medication exposure, and reminding parents to store all medicines out of the reach and sight of young children is a top CHPA priority.”

Top-tier recommendations from the 2011 FDA Voluntary Guidance and

Error. Page cannot be displayed. Please contact your service provider for more details. (8)

2009 CHPA Voluntary Guidance include the following:

  • Dosing devices should be included with all products
  • Atypical units should not be used (eg, drams, dropperfuls)
  • Teaspoon and
tablespoon units should not be used together
  • Trailing zeros should not be used (to avoid 10-fold dosing errors)
  • Leading zeros should be used before decimal doses <1 (to avoid 10-fold dosing errors)
  • Small font should be used with numerals in fractions (to avoid interpreting “1/2” as “1 or 2”)
  • Dosing devices should not bear extraneous or unnecessary volumetric units
  • Dosing devices should not be significantly larger than the largest doses in the directions
  • Dosing devices should provide markings that can readily measure doses in the directions
  • The Consumer Healthcare Products Association (CHPA) is the 133-year-old trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines and dietary supplements. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system $6-$7, contributing a total of $102 billion in savings each year. CHPA is committed to promoting the increasingly vital role of over-the-counter medicines and dietary supplements in America’s healthcare system through science, education, and advocacy.

    chpa.org

    Contacts

    Consumer Healthcare Products Association (CHPA)
    Jenni Terry, 202-429-9260


    Source: Consumer Healthcare Products Association (CHPA)




    BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

    Add this page to your favorite Social Bookmarking websites
    Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
     
    BMR:1